Lumos Pharma Inc (LUMO)
2.286
+0.03
(+1.55%)
USD |
NASDAQ |
Jun 28, 16:00
2.25
-0.04
(-1.57%)
After-Hours: 20:00
Lumos Pharma Cash from Investing (Quarterly): 1.00M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.00M |
| December 31, 2023 | 6.172M |
| September 30, 2023 | 5.95M |
| June 30, 2023 | 1.083M |
| March 31, 2023 | -2.463M |
| December 31, 2022 | -11.36M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | -0.03M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 26.00M |
| December 31, 2020 | -0.012M |
| September 30, 2020 | 32.50M |
| June 30, 2020 | -0.014M |
| March 31, 2020 | 84.18M |
| December 31, 2019 | -0.002M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.006M |
| September 30, 2018 | 0.01M |
| June 30, 2018 | 0.018M |
| March 31, 2018 | 0.083M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.069M |
| September 30, 2017 | 0.027M |
| June 30, 2017 | 0.128M |
| March 31, 2017 | -0.013M |
| December 31, 2016 | -0.177M |
| September 30, 2016 | -0.085M |
| June 30, 2016 | -0.706M |
| March 31, 2016 | 0.902M |
| December 31, 2015 | 0.491M |
| September 30, 2015 | -0.291M |
| June 30, 2015 | 2.133M |
| March 31, 2015 | 3.885M |
| December 31, 2014 | 3.887M |
| September 30, 2014 | -17.43M |
| June 30, 2014 | -0.204M |
| March 31, 2014 | -0.093M |
| December 31, 2013 | -0.355M |
| September 30, 2013 | -0.757M |
| June 30, 2013 | 0.286M |
| March 31, 2013 | 0.685M |
| December 31, 2012 | 1.059M |
| September 30, 2012 | -2.015M |
| June 30, 2012 | 1.338M |
| March 31, 2012 | -0.659M |
| December 31, 2011 | -2.677M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-11.36M
Minimum
Dec 2022
84.18M
Maximum
Mar 2020
7.150M
Average
--
Median
Jun 2019
Cash from Investing (Quarterly) Benchmarks
| icad Inc | -0.206M |
| Perspective Therapeutics Inc | -47.30M |
| Palatin Technologies Inc | 0.00 |
| Bio-Path Holdings Inc | -- |
| PDS Biotechnology Corp | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.89M |
| Cash from Financing (Quarterly) | -0.005M |
| Free Cash Flow | -34.79M |
| Free Cash Flow Per Share (Quarterly) | -1.591 |
| Free Cash Flow to Equity (Quarterly) | -12.89M |
| Free Cash Flow Yield | -188.0% |